In Silico Analysis of the Interaction of Marine-derived Bioactive Compounds with the NLRP3 Inflammasome NACHT Domain

14 June 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Cell death plays a homeostatic role in the life of a multicellular organism such as in removing damaged, unwanted, or excess cells, and aiding the normal development of organisms. Pyroptosis is an immunomodulatory form of regulated cell death that is mediated by the pore-forming action of the gasdermin protein family, and has been linked to various diseases including cancer, neurodegeneration, and infection. Targeting pyroptosis therefore could have potential therapeutic benefit, for instance, via the inhibition of its execution. In this regard, marine-derived compounds can offer possible novel structures and scaffolds by which potential pyroptosis inhibitors can be designed. In this study 153 mareine-derived compounds were investigated for their in silico interaction with the NLRP3 inflammasome NACHT domain through molecular docking, ADMET profiling, and key interaction analysis. Docking of the compounds on the target protein based on a previously solved co-crystal structure yielded binding free energy (BFE) values between–10.8 to 82 kcal/mol. Interactions of the top-performing compounds with critical protein residues were predominantly non-covalent in nature and displayed a great degree of similarity to the co-crystalized inhibitor. The top performing compounds also displayed drug-likeness with varying levels of toxicity risks based on ADMET analysis, and (S)-6’-debromohamacanthin was determined to have the most potential having zero Lipinski violations and exhibiting no toxicity risks.

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.